A carregar cotações...
Previsão
| Comprar |
1 |
| Manter |
2 |
| Vender |
1 |
Notícias Ir para o feed de notícias
Carl Zeiss Meditec: investment ten years ago would mean around 25% loss
An investment of EUR 100 in Carl Zeiss Meditec ten years ago would today have resulted in 2.916 shares and was worth only EUR 74.82 as of 20 May 2026, corresponding to a performance of −25.18%. The market value of all Carl Zeiss Meditec shares most recently stood at EUR 2.21 billion. Calculation does not take into account stock splits or dividends. » Mais em finanzen.net
Carl Zeiss Meditec rises after announcement of extensive cost cuts
Shares of Carl Zeiss Meditec jumped sharply after initially volatile trading on Tuesday, trading 7.4 percent higher at €27.46 around midday. Investors reacted positively to announced cost cuts and an ongoing restructuring that UBS analyst Graham Doyle called groundbreaking. In the short term the stock climbed above the 21‑day line, but the longer‑term downtrend in place since 2012 remains intact. » Mais em de.investing.com
Carl Zeiss Meditec recovers after cautiously optimistic comment from Goldman Sachs
After cautiously optimistic remarks from Goldman Sachs, Carl Zeiss Meditec’s shares rose by up to 5% on Tuesday and were trading at €25.64 in the morning. Analyst Richard Felton sees short-term upside potential due to expected cost savings and a more coherent portfolio, and a possible reinstatement of the fiscal 2026 targets in upcoming quarterly results. The stock had fallen two weeks earlier to its lowest level since 2015; earnings estimates for 2026–2028 have been cut by 22–29% since the start of the year. » Mais em de.investing.com
Dividendos históricos Dividendos
Todos os indicadores de dividendos Todos os indicadoresDados financeiros da empresa
| (EUR) | junho de 2026 | |
|---|---|---|
| Receitas | 562,72 mi | 2,38% |
| Ganho bruto | 302,28 mi | 4,34% |
| Ganho líquido | 55,03 mi | 93,94% |
| EBITDA | 74,87 mi | 31,20% |
Dados fundamentais
| Métrica | Valor |
|---|---|
Capitalização bolsista | € 2,65 bi |
Número de ações | 87,54 mi |
Máximo/mínimo de 52 semanas | € 48,21 - € 22,97 |
Rentabilidade de dividendos | 1,75% |
Dividendos TTM | € 0,53 |
Beta | 1,47 |
PER (PE Ratio) | 18,14 |
PEG (PEG Ratio) | -5,23 |
P/VC (PB Ratio) | 1,24 |
P/V (PS Ratio) | 1,00 |
Perfil da empresa
Die Carl Zeiss Meditec AG ist als Medizintechnikunternehmen in Deutschland, dem übrigen Europa, den Vereinigten Staaten, Asien und international tätig. Es ist in zwei Segmenten tätig, Ophthalmic Devices und Microsurgery. Das Segment Ophthalmic Devices bietet Produkte und Lösungen für die Diagnose und Behandlung von Augenkrankheiten sowie Systeme und Verbrauchsmaterialien für Katarakt-, Netzhaut- und refraktive Operationen an. Das Unternehmen beliefert praktizierende Ophthalmologen und Optometristen sowie Ärzte und Chirurgen in Krankenhäusern und ambulanten Operationszentren. Das Segment Mikrochirurgie bietet Visualisierungslösungen für invasive chirurgische Behandlungen sowie Lösungen in den Bereichen Hals-, Nasen- und Ohrenheilkunde, plastische und rekonstruktive Chirurgie, Zahn- und Wirbelsäulenchirurgie. Das Unternehmen beliefert Ärzte in verschiedenen Bereichen und Krankenhäuser. Das Unternehmen wurde 1846 gegründet und hat seinen Hauptsitz in Jena, Deutschland. Die Carl Zeiss Meditec AG ist eine Tochtergesellschaft der Carl Zeiss AG.
| Nome | CARL ZEISS MEDITEC ADR 1 |
| CEO | Andreas Pecher |
| Sede | Jena,
th Alemanha |
| Site | |
| Setor | Cuidados de saúde |
| Indústria | Cuidados de saúde: equipamentos e produtos |
| Entrada em bolsa | 03/08/2012 |
| Colaboradores | 5.784 |
Símbolos de ticker
| Bolsa | Símbolo |
|---|---|
Pnk | CZMWY |
Frankfurt | AFXA.F |
Düsseldorf | AFXA.DU |
München | AFXA.MU |
